Hypermobile Ehlers‐Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes

The Ehlers‐Danlos syndromes (EDS) are a group of heritable, connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. There is phenotypic and genetic variation among the 13 subtypes. The initial genetic findings on EDS were related to alterations in fibrillar collagen, but the elucidation of the molecular basis of many of the subtypes revealed several genes not involved in collagen biosynthesis or structure. However, the genetic basis of the hypermobile type of EDS (hEDS) is still unknown. hEDS is the most common type of EDS and involves generalized joint hypermobility, musculoskeletal manifestations, and mild skin involvement along with the presence of several comorbid conditions. Variability in the spectrum and severity of symptoms and progression of patient phenotype likely depend on age, gender, lifestyle, and expression domains of the EDS genes during development and postnatal life. In this review, we summarize the current molecular, genetic, epidemiologic, and pathogenetic findings related to EDS with a focus on the hypermobile type.

[1]  G. Cruccu,et al.  Pain due to Ehlers-Danlos Syndrome Is Associated with Deficit of the Endogenous Pain Inhibitory Control. , 2020, Pain medicine.

[2]  D. Baker,et al.  Electron microscopy in the diagnosis of Ehlers–Danlos syndromes: correlation with clinical and genetic investigations , 2020, British Journal of Dermatology.

[3]  Michael V. Boland,et al.  Survey of Ehlers‒Danlos Patients’ ophthalmic surgery experiences , 2020, Molecular genetics & genomic medicine.

[4]  Amy C. Arnold,et al.  Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome , 2020, Autonomic Neuroscience.

[5]  N. Miyake,et al.  Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome , 2019, Genes.

[6]  J. So,et al.  Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers–Danlos syndrome clinic: A retrospective review , 2019, American journal of medical genetics. Part A.

[7]  C. Craven,et al.  EXTRADURAL COMPRESSIVE SPINAL CEREBROSPINAL FLUID LEAK IN EHLERS-DANLOS SYNDROME. , 2019, World neurosurgery.

[8]  T. Mazza,et al.  Novel TNXB Variants in Two Italian Patients with Classical-Like Ehlers-Danlos Syndrome , 2019, Genes.

[9]  Joanne C. Demmler,et al.  Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case–control comparison , 2019, BMJ Open.

[10]  M. Ritelli,et al.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant , 2019, Genes.

[11]  H. Dietz,et al.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome. , 2019, The Journal of clinical investigation.

[12]  O. Doğanlar,et al.  Ehlers–Danlos syndrome-related genes and serum strontium, zinc, and lithium levels in generalized joint hypermobility: a case-control study , 2019, Connective tissue research.

[13]  S. Raj,et al.  Resistance to local anesthesia in people with the Ehlers-Danlos Syndromes presenting for dental surgery , 2019, Journal of dental anesthesia and pain medicine.

[14]  M. Copetti,et al.  Severity classes in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders: a pilot study of 105 Italian patients. , 2019, Rheumatology.

[15]  Lois J. Starr,et al.  Utilization of echocardiography in Ehlers-Danlos syndrome. , 2019, Congenital heart disease.

[16]  N. Matsumoto,et al.  Measurement of Serum Tenascin-X in Joint Hypermobility Syndrome Patients. , 2019, Biological & pharmaceutical bulletin.

[17]  Q. Lao,et al.  High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. , 2019, The Journal of molecular diagnostics : JMD.

[18]  L. Sonnesen,et al.  Oro-dental characteristics in patients with hypermobile Ehlers Danlos Syndrome compared to a healthy control group. , 2019, Journal of oral rehabilitation.

[19]  D. Deyle,et al.  Fracture incidence in Ehlers-Danlos syndrome - A population-based case-control study. , 2019, Child abuse & neglect.

[20]  A. Kline,et al.  Factors affecting quality of life in children and adolescents with hypermobile Ehlers‐Danlos syndrome/hypermobility spectrum disorders , 2019, American journal of medical genetics. Part A.

[21]  M. Ritelli,et al.  Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients’ skin fibroblasts , 2019, PloS one.

[22]  A. Formenti,et al.  Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome , 2019, Genes.

[23]  C. Francomano,et al.  Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome , 2018, Autonomic Neuroscience.

[24]  T. Gaisl,et al.  Obstructive Sleep Apnoea in Children and Adolescents with Ehlers-Danlos Syndrome , 2018, Respiration.

[25]  Staci Kallish,et al.  Mitral valve prolapse and aortic root dilation in adults with hypermobile Ehlers–Danlos syndrome and related disorders , 2018, American journal of medical genetics. Part A.

[26]  A. Polimeni,et al.  Evaluation of Temporomandibular Disorders and Comorbidities in Patients with Ehler-–Danlos: Clinical and Digital Findings , 2018, Journal of International Society of Preventive & Community Dentistry.

[27]  N. Simakajornboon,et al.  Sleep Disorders and Their Management in Children With Ehlers-Danlos Syndrome Referred to Sleep Clinics. , 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[28]  J. Parisi,et al.  Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome. , 2018, American journal of human genetics.

[29]  M. Ritelli,et al.  Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[30]  Emily L. Casanova,et al.  A Cohort Study Comparing Women with Autism Spectrum Disorder with and without Generalized Joint Hypermobility , 2018, Behavioral sciences.

[31]  John E Mitakides The effect of Ehlers-Danlos syndromes on TMJ function and craniofacial pain , 2018, Cranio : the journal of craniomandibular practice.

[32]  T. Hermanns‐Lê,et al.  [Severe Mast Cell Activation Syndrome in a 15-year-old patient with an hypermobile Ehlers-Danlos syndrome]. , 2018, Revue medicale de Liege.

[33]  T. Bernadzikowski,et al.  Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program , 2018, Cardiology in the Young.

[34]  Ken-ichi Matsumoto,et al.  Wound healing‐related properties detected in an experimental model with a collagen gel contraction assay are affected in the absence of tenascin‐X , 2017, Experimental cell research.

[35]  L. Soslowsky,et al.  Collagen V haploinsufficiency in a murine model of classic Ehlers–Danlos syndrome is associated with deficient structural and mechanical healing in tendons , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[36]  D. Shehab,et al.  Prevalence of joint hypermobility in Kuwait , 2017, International journal of rheumatic diseases.

[37]  R. Engelbert,et al.  Generalized Hyperalgesia in Children and Adults Diagnosed With Hypermobility Syndrome and Ehlers‐Danlos Syndrome Hypermobility Type: A Discriminative Analysis , 2017, Arthritis care & research.

[38]  D. Long,et al.  Neurological and spinal manifestations of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[39]  J. Belmont,et al.  The 2017 international classification of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[40]  S. Seneviratne,et al.  Mast cell disorders in Ehlers–Danlos syndrome , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[41]  A. Hakim,et al.  Cardiovascular autonomic dysfunction in Ehlers–Danlos syndrome—Hypermobile type , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[42]  A. Hakim,et al.  Chronic fatigue in Ehlers–Danlos syndrome—Hypermobile type , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[43]  R. Grahame,et al.  Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[44]  A. Bulbena,et al.  Pain management in the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[45]  R. Engelbert,et al.  The evidence‐based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[46]  R. Grahame,et al.  A framework for the classification of joint hypermobility and related conditions , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[47]  R. Wolman,et al.  Orthopaedic management of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[48]  B. Tinkle,et al.  Oral and mandibular manifestations in the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[49]  J. Stoler,et al.  Musculoskeletal Conditions in a Pediatric Population with Ehlers‐Danlos Syndrome , 2017, The Journal of pediatrics.

[50]  C. Bönnemann,et al.  Novel Col12A1 variant expands the clinical picture of congenital myopathies with extracellular matrix defects , 2017, Muscle & nerve.

[51]  D. Bratton,et al.  Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study , 2017, Thorax.

[52]  J. Ludvigsson,et al.  Pregnancy outcome in joint hypermobility syndrome and Ehlers–Danlos syndrome , 2017, Acta Obstetricia et Gynecologica Scandinavica.

[53]  M. Lind,et al.  The Danish Knee Ligament Reconstruction Registry , 2016, Clinical epidemiology.

[54]  Andrew J. Oler,et al.  Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number , 2016, Nature Genetics.

[55]  D. Nickerson,et al.  Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement , 2016, American journal of human genetics.

[56]  A. Gompel,et al.  Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study , 2016, Orphanet Journal of Rare Diseases.

[57]  M. Venturini,et al.  Transcriptome-Wide Expression Profiling in Skin Fibroblasts of Patients with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome Hypermobility Type , 2016, PloS one.

[58]  G. Lauria,et al.  Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes , 2016, Neurology.

[59]  N. Foulds,et al.  Further defining the phenotypic spectrum of B4GALT7 mutations , 2016, American journal of medical genetics. Part A.

[60]  M. Butler,et al.  Mutation in TNXB gene causes moderate to severe Ehlers-Danlos syndrome , 2016, World journal of medical genetics.

[61]  E. Honey Spondyloepimetaphyseal dysplasia with joint laxity (Beighton type): A unique South African disorder. , 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[62]  M. Venturini,et al.  Further delineation of FKBP14‐related Ehlers–Danlos syndrome: A patient with early vascular complications and non‐progressive kyphoscoliosis, and literature review , 2016, American journal of medical genetics. Part A.

[63]  B. Marinelli,et al.  Bone involvement in adult patients affected with Ehlers-Danlos syndrome. , 2016, Osteoporosis International.

[64]  Z. Gugala,et al.  Effects of Oral Contraceptive Use on Anterior Cruciate Ligament Injury Epidemiology. , 2016, Medicine and science in sports and exercise.

[65]  P. Calzavara-Pinton,et al.  High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome. , 2016, Bone.

[66]  M. Jen,et al.  Ocular manifestations of genetic skin disorders. , 2016, Clinics in dermatology.

[67]  H. Faghfoury,et al.  Psychiatric disorders in Ehlers–Danlos syndrome are frequent, diverse and strongly associated with pain , 2016, Rheumatology International.

[68]  K. Devriendt,et al.  Expanding the clinical and mutational spectrum of the Ehlers–Danlos syndrome, dermatosparaxis type , 2016, Genetics in Medicine.

[69]  H. M. Geller,et al.  The phenotype of the musculocontractural type of Ehlers‐Danlos syndrome due to CHST14 mutations , 2016, American journal of medical genetics. Part A.

[70]  M. Castori Ehlers–Danlos syndrome(s) mimicking child abuse: Is there an impact on clinical practice? , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.

[71]  Hao Huang,et al.  Dermatological Manifestations of Postural Tachycardia Syndrome Are Common and Diverse , 2015, Journal of clinical neurology.

[72]  M. Camilleri,et al.  Ehlers Danlos syndrome and gastrointestinal manifestations: a 20‐year experience at Mayo Clinic , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[73]  A. De Paepe,et al.  Ehlers-Danlos Syndrome, Hypermobility Type, Is Linked to Chromosome 8p22-8p21.1 in an Extended Belgian Family , 2015, Disease markers.

[74]  Stephanie A. H. Jones,et al.  Proprioceptive precision is impaired in Ehlers–Danlos syndrome , 2015, SpringerPlus.

[75]  R. Adams,et al.  Quality of life prediction in children with joint hypermobility syndrome , 2015, Journal of paediatrics and child health.

[76]  B. Bachmann,et al.  Brittle Cornea Syndrome: Case Report with Novel Mutation in the PRDM5 Gene and Review of the Literature , 2015, Case reports in ophthalmological medicine.

[77]  A. Arai,et al.  Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia. , 2015, The Journal of clinical endocrinology and metabolism.

[78]  E. Puentedura,et al.  Safety of thrust joint manipulation in the thoracic spine: a systematic review , 2015, The Journal of manual & manipulative therapy.

[79]  J. Morton,et al.  Genetic Heterogeneity and Clinical Variability in Musculocontractural Ehlers–Danlos Syndrome Caused by Impaired Dermatan Sulfate Biosynthesis , 2015, Human mutation.

[80]  P. Beighton,et al.  Spondyloepimetaphyseal dysplasia with joint laxity (Beighton type); mutation analysis in eight affected South African families , 2015, Clinical genetics.

[81]  L. Soslowsky,et al.  Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype. , 2015, The American journal of pathology.

[82]  A. Hohler,et al.  A Survey-Based Analysis of Symptoms in Patients with Postural Orthostatic Tachycardia Syndrome , 2015, Proceedings.

[83]  E. Vicenzini,et al.  A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers–Danlos syndrome, hypermobility type , 2015, Neurological Sciences.

[84]  É. Mousseaux,et al.  The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndrome , 2015, European Journal of Human Genetics.

[85]  T. Thillemann,et al.  Is the Use of Oral Contraceptives Associated With Operatively Treated Anterior Cruciate Ligament Injury? , 2014, The American journal of sports medicine.

[86]  M. Venturini,et al.  Insights in the etiopathology of galactosyltransferase II (GalT-II) deficiency from transcriptome-wide expression profiling of skin fibroblasts of two sisters with compound heterozygosity for two novel B3GALT6 mutations , 2014, Molecular genetics and metabolism reports.

[87]  F. Alkuraya,et al.  Excessively redundant umbilical skin as a potential early clinical feature of Morquio syndrome and FKBP14‐related Ehlers–Danlos syndrome , 2014, Clinical genetics.

[88]  M. Castori,et al.  Neurological manifestations of Ehlers-Danlos syndrome(s): A review , 2014, Iranian journal of neurology.

[89]  M. E. Wilson,et al.  Brittle cornea syndrome: a case report and comparison with Ehlers Danlos syndrome. , 2014, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[90]  M. Castori,et al.  Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(s) , 2014, Orphanet Journal of Rare Diseases.

[91]  P. Byers,et al.  FKBP14‐related Ehlers‐Danlos syndrome: Expansion of the phenotype to include vascular complications , 2014, American Journal of Medical Genetics. Part A.

[92]  E. Tkacz,et al.  Correlation between TMD and Cervical Spine Pain and Mobility: Is the Whole Body Balance TMJ Related? , 2014, BioMed research international.

[93]  P. Byers,et al.  Survival is affected by mutation type and molecular mechanism in vascular Ehlers–Danlos syndrome (EDS type IV) , 2014, Genetics in Medicine.

[94]  G. B. Schaefer,et al.  A newborn with complex skeletal abnormalities, joint contractures, and bilateral corneal clouding with sclerocornea. , 2014, Seminars in pediatric neurology.

[95]  A. Dinç,et al.  AB0866 Presence of Acrocyanosis in Patients with Joint Hypermobility , 2014 .

[96]  J. Weinberg,et al.  Ehlers–Danlos Syndrome and Postural Tachycardia Syndrome: A relationship study , 2014, Journal of the Neurological Sciences.

[97]  M. Devoto,et al.  Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice. , 2014, Human molecular genetics.

[98]  K. Bushby,et al.  Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. , 2014, Human molecular genetics.

[99]  T. Hashimoto,et al.  The first Japanese case of the arthrochalasia type of Ehlers-Danlos syndrome with COL1A2 gene mutation. , 2014, Gene.

[100]  B. Hurst,et al.  Obstetric and Gynecologic Challenges in Women With Ehlers-Danlos Syndrome , 2014, Obstetrics and gynecology.

[101]  Shlomo Shinnar,et al.  Abnormalities of joint mobility and gait in children with autism spectrum disorders , 2014, Brain and Development.

[102]  I. Sobhani,et al.  Functional Digestive Symptoms and Quality of Life in Patients with Ehlers-Danlos Syndromes: Results of a National Cohort Study on 134 Patients , 2013, PloS one.

[103]  Daniel A. London,et al.  Ligamentous hyperlaxity and dorsal wrist ganglions. , 2013, The Journal of hand surgery.

[104]  C. Guilleminault,et al.  Sleep-disordered breathing in Ehlers-Danlos syndrome: a genetic model of OSA. , 2013, Chest.

[105]  Michael H. Guo,et al.  Redefining the progeroid form of ehlers–danlos syndrome: Report of the fourth patient with B4GALT7 deficiency and review of the literature , 2013, American journal of medical genetics. Part A.

[106]  A. Janecke,et al.  Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome. , 2013, Human molecular genetics.

[107]  D. Henriques,et al.  Proprioceptive sensitivity in Ehlers–Danlos syndrome patients , 2013, Experimental Brain Research.

[108]  D. Symmons,et al.  Modest Association of Joint Hypermobility With Disabling and Limiting Musculoskeletal Pain: Results From a Large‐Scale General Population–Based Survey , 2013, Arthritis care & research.

[109]  D. Sillence,et al.  ZNF469 frequently mutated in the brittle cornea syndrome (BCS) is a single exon gene possibly regulating the expression of several extracellular matrix components , 2013, Molecular genetics and metabolism.

[110]  D. Chitayat,et al.  Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders. , 2013, American journal of human genetics.

[111]  A. Kariminejad,et al.  Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder. , 2013, American journal of human genetics.

[112]  H. Khalil,et al.  A case report of obstetrical management of a pregnancy with hypermobile Ehlers–Danlos syndrome and literature review , 2013, Obstetric medicine.

[113]  Alan J. Hakim,et al.  Arachnodactyly—a key to diagnosing heritable disorders of connective tissue , 2013, Nature Reviews Rheumatology.

[114]  A. Bharucha,et al.  Gastric emptying in postural tachycardia syndrome: a preliminary report , 2013, Clinical Autonomic Research.

[115]  L. Garavelli,et al.  Clinical and molecular characterization of 40 patients with classic Ehlers–Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations , 2013, Orphanet Journal of Rare Diseases.

[116]  T. D. de Backer,et al.  Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos syndrome. , 2013, Research in developmental disabilities.

[117]  S. Johansson,et al.  MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing , 2013, Orphanet Journal of Rare Diseases.

[118]  R. Grahame,et al.  Prolapse and sexual function in women with benign joint hypermobility syndrome , 2013, BJOG : an international journal of obstetrics and gynaecology.

[119]  F. Alkuraya,et al.  Identification of a novel ZNF469 mutation in a large family with Ehlers-Danlos phenotype. , 2012, Gene.

[120]  M. Castori Ehlers-Danlos Syndrome, Hypermobility Type: An Underdiagnosed Hereditary Connective Tissue Disorder with Mucocutaneous, Articular, and Systemic Manifestations , 2012, ISRN dermatology.

[121]  F. Alkuraya,et al.  Brittle cornea without clinically-evident extraocular findings in an adult harboring a novel homozygous ZNF469 mutation , 2012, Ophthalmic genetics.

[122]  P. Delvenne,et al.  Dermal Ultrastructure in Low Beighton Score Members of 17 Families with Hypermobile-Type Ehlers-Danlos Syndrome , 2012, Journal of biomedicine & biotechnology.

[123]  A. De Paepe,et al.  Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria , 2012, Human mutation.

[124]  M. Castori,et al.  Ocular features in joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. , 2012, American journal of ophthalmology.

[125]  G. Pals,et al.  Ehlers–Danlos arthrochalasia type (VIIA–B) – expanding the phenotype: from prenatal life through adulthood , 2012, Clinical genetics.

[126]  D. Rimoin,et al.  Ehlers–Danlos syndrome type VIII is clinically heterogeneous disorder associated primarily with periodontal disease, and variable connective tissue features , 2012, European Journal of Human Genetics.

[127]  J. Cleland,et al.  Safety of cervical spine manipulation: are adverse events preventable and are manipulations being performed appropriately? A review of 134 case reports , 2012, The Journal of manual & manipulative therapy.

[128]  P. Rowe,et al.  Pain intensity and quality of life perception in children with hypermobility syndrome , 2012, Rheumatology International.

[129]  F. Muntoni,et al.  Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. , 2012, American journal of human genetics.

[130]  F. Alkuraya,et al.  A novel mutation in PRDM5 in brittle cornea syndrome , 2012, Clinical genetics.

[131]  J. Mathew,et al.  Evaluation of posture and pain in persons with benign joint hypermobility syndrome , 2011, Rheumatology International.

[132]  M. Castori,et al.  Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type). , 2011, Clinical and experimental rheumatology.

[133]  A. De Paepe,et al.  Balance, gait, falls, and fear of falling in women with the hypermobility type of Ehlers‐Danlos syndrome , 2011, Arthritis care & research.

[134]  J. A. van der Laak,et al.  Mild Muscular Features in Tenascin-X Knockout Mice, A Model of Ehlers–Danlos Syndrome , 2011, Connective tissue research.

[135]  M. Castori,et al.  Screening for celiac disease in the joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type , 2011, American journal of medical genetics. Part A.

[136]  Chris Riddoch,et al.  Epidemiology of Generalized Joint Laxity (Hypermobility) in Fourteen-Year-Old Children From the UK: A Population-Based Evaluation , 2011, Arthritis and rheumatism.

[137]  V. Cimolin,et al.  Gait strategy in patients with Ehlers-Danlos syndrome hypermobility type: a kinematic and kinetic evaluation using 3D gait analysis. , 2011, Research in developmental disabilities.

[138]  D. Judge,et al.  Mitral Valve Disease in Marfan Syndrome and Related Disorders , 2011, Journal of cardiovascular translational research.

[139]  J. Clayton-Smith,et al.  Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance. , 2011, American journal of human genetics.

[140]  G. Bleijenberg,et al.  Fatigue is associated with muscle weakness in Ehlers-Danlos syndrome: an explorative study. , 2011, Physiotherapy.

[141]  Manuela Galli,et al.  The effects of muscle hypotonia and weakness on balance: a study on Prader-Willi and Ehlers-Danlos syndrome patients. , 2011, Research in developmental disabilities.

[142]  H. Knoop,et al.  High frequency of neuropathic pain in Ehlers-Danlos syndrome: an association with axonal polyneuropathy and compression neuropathy? , 2011, Journal of pain and symptom management.

[143]  M. Castori,et al.  Chronic fatigue syndrome is commonly diagnosed in patients with Ehlers-Danlos syndrome hypermobility type/joint hypermobility syndrome. , 2011, Clinical and experimental rheumatology.

[144]  O. V. Potapova,et al.  Structural and Functional Peculiarities of Mast Cells in Undifferentiated Connective Tissue Dysplasia , 2011, Bulletin of Experimental Biology and Medicine.

[145]  H. Knoop,et al.  Both pain and fatigue are important possible determinants of disability in patients with the Ehlers-Danlos syndrome hypermobility type , 2011, Disability and rehabilitation.

[146]  G. Bleijenberg,et al.  Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos Syndrome. , 2010, Seminars in arthritis and rheumatism.

[147]  S. Nampoothiri,et al.  Musculocontractural Ehlers‐Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan‐4‐sulfotransferase 1 encoding CHST14 gene , 2010, Human mutation.

[148]  L. Padua,et al.  Ehlers–Danlos syndrome hypermobility type and the excess of affected females: Possible mechanisms and perspectives , 2010, American journal of medical genetics. Part A.

[149]  Y. Fukushima,et al.  Loss‐of‐function mutations of CHST14 in a new type of Ehlers‐Danlos syndrome , 2010, Human mutation.

[150]  V. Saraceni,et al.  Natural history and manifestations of the hypermobility type Ehlers–Danlos syndrome: A pilot study on 21 patients , 2010, American journal of medical genetics. Part A.

[151]  A. Farmer,et al.  Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[152]  A. De Paepe,et al.  Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers–Danlos syndrome hypermobility type , 2010, Disability and rehabilitation.

[153]  R. Grahame Joint hypermobility syndrome pain , 2009, Current pain and headache reports.

[154]  D. Sillence,et al.  The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome) , 2009, American journal of medical genetics. Part A.

[155]  L. Vaillant,et al.  Contribution of skin biometrology to the diagnosis of the Ehlers–Danlos syndrome in a prospective series of 41 patients , 2009, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[156]  J. Beckmann,et al.  Correction: The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-β Signaling Pathways , 2008, PLoS ONE.

[157]  J. Beckmann,et al.  The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-β Signaling Pathways , 2008, PloS one.

[158]  N. Elçioglu,et al.  Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome--an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. , 2008, American journal of human genetics.

[159]  M. Frydman,et al.  Deleterious mutations in the Zinc-Finger 469 gene cause brittle cornea syndrome. , 2008, American journal of human genetics.

[160]  Y. Kurozawa,et al.  Relationship of the menstrual cycle phase to anterior cruciate ligament injuries in teenaged female athletes , 2008, Archives of Orthopaedic and Trauma Surgery.

[161]  R. Keer,et al.  Hypermobility and the hypermobility syndrome, part 2: assessment and management of hypermobility syndrome: illustrated via case studies. , 2008, Manual therapy.

[162]  H. Ugurlu,et al.  Evaluation of knee proprioception and effects of proprioception exercise in patients with benign joint hypermobility syndrome , 2008, Rheumatology International.

[163]  P. Bolognese,et al.  Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue. , 2007, Journal of neurosurgery. Spine.

[164]  R. Keer,et al.  Hypermobility and the hypermobility syndrome. , 2007, Manual therapy.

[165]  G. Piérard,et al.  Ultrastructural Alterations of Elastic Fibers and Other Dermal Components in Ehlers-Danlos Syndrome of the Hypermobile Type , 2007, The American Journal of dermatopathology.

[166]  A. Morgan,et al.  Asthma and airways collapse in two heritable disorders of connective tissue , 2007, Annals of the rheumatic diseases.

[167]  A. De Paepe,et al.  Three arginine to cysteine substitutions in the pro‐alpha (I)‐collagen chain cause Ehlers‐Danlos syndrome with a propensity to arterial rupture in early adulthood , 2007, Human mutation.

[168]  O. Şendur,et al.  The frequency of hypermobility and its relationship with clinical findings of fibromyalgia patients , 2007, Clinical Rheumatology.

[169]  A. Hakim,et al.  Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. , 2006, Clinics in dermatology.

[170]  L. Carrasco,et al.  Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[171]  I. Chervoneva,et al.  Murine Model of the Ehlers-Danlos Syndrome , 2006, Journal of Biological Chemistry.

[172]  B. Beynnon,et al.  The Relationship between Menstrual Cycle Phase and Anterior Cruciate Ligament Injury , 2006, The American journal of sports medicine.

[173]  D. Ofluoğlu,et al.  Hypermobility in women with fibromyalgia syndrome , 2006, Clinical Rheumatology.

[174]  B. Engelen,et al.  Recurrent neuropathy associated with Ehlers–Danlos syndrome , 2006, Journal of Neurology.

[175]  T. Kobayasi Dermal elastic fibres in the inherited hypermobile disorders. , 2006, Journal of dermatological science.

[176]  J. Bravo,et al.  Clinical study of hereditary disorders of connective tissues in a Chilean population: joint hypermobility syndrome and vascular Ehlers-Danlos syndrome. , 2006, Arthritis and rheumatism.

[177]  S. Najjar,et al.  Echocardiographic findings in classical and hypermobile Ehlers–Danlos syndromes , 2006, American journal of medical genetics. Part A.

[178]  A. De Paepe,et al.  Total absence of the α2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems , 2005, Journal of Medical Genetics.

[179]  J. Schalkwijk,et al.  Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[180]  C. Giunta,et al.  Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA). , 2005, Molecular genetics and metabolism.

[181]  R. Grahame,et al.  Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? , 2005, Rheumatology.

[182]  S. Wientroub,et al.  Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment , 2005, Journal of Medical Genetics.

[183]  M. Yamauchi,et al.  A novel mutation in the lysyl hydroxylase 1 gene causes decreased lysyl hydroxylase activity in an Ehlers-Danlos VIA patient. , 2005, The Journal of investigative dermatology.

[184]  A. De Paepe,et al.  Oral health in prevalent types of Ehlers-Danlos syndromes. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[185]  T. Arasıl,et al.  The prevalence of joint hypermobility among high school students , 2005, Rheumatology International.

[186]  J. Schalkwijk,et al.  Elastic fiber abnormalities in hypermobility type Ehlers–Danlos syndrome patients with tenascin‐X mutations , 2005, Clinical genetics.

[187]  G. Nordström,et al.  Foot pain and disability in individuals with Ehlers – Danlos syndrome (EDS): Impact on daily life activities , 2005, Disability and rehabilitation.

[188]  R. Grahame,et al.  Local Anaesthetic Failure in Joint Hypermobility Syndrome , 2005 .

[189]  A. Paepe,et al.  Bleeding and bruising in patients with Ehlers–Danlos syndrome and other collagen vascular disorders , 2004, British journal of haematology.

[190]  J. Oosterwijk,et al.  Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. , 2004, The Journal of investigative dermatology.

[191]  R. Grahame,et al.  Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? , 2004, Rheumatology.

[192]  P. Renström,et al.  General joint laxity in 1845 Swedish school children of different ages: age‐ and gender‐specific distributions , 2004, Acta paediatrica.

[193]  T. Kobayasi Abnormality of dermal collagen fibrils in Ehlers Danlos syndrome. Anticipation of the abnormality for the inherited hypermobile disorders. , 2004, European journal of dermatology : EJD.

[194]  L. Tsui,et al.  A novel missense mutation in the galactosyltransferase‐I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers–Danlos syndrome resembling the progeroid type , 2004, American journal of medical genetics. Part A.

[195]  A. Palit,et al.  Cutaneous signs in heritable disorders of the connective tissue. , 2004, Indian journal of dermatology, venereology and leprology.

[196]  P. Byers,et al.  Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. , 2004, American journal of human genetics.

[197]  A. De Paepe,et al.  Human Fibroblasts with Mutations in COL5A1 and COL3A1 Genes Do Not Organize Collagens and Fibronectin in the Extracellular Matrix, Down-regulate α2β1 Integrin, and Recruit αvβ3 Instead of α5β1 Integrin* , 2004, Journal of Biological Chemistry.

[198]  J. Brinckmann,et al.  Reduced skin thickness: a new minor diagnostic criterion for the classical and hypermobility types of Ehlers–Danlos syndrome , 2003, The British journal of dermatology.

[199]  B. Hamel,et al.  Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. , 2003, American journal of human genetics.

[200]  A. Superti-Furga,et al.  The Ehlers‐Danlos Syndrome , 2003 .

[201]  R. Grahame,et al.  A SIMPLE QUESTIONNAIRE TO DETECT HYPERMOBILITY: AN ADJUNCT TO THE ASSESSMENT OF PATIENTS WITH DIFFUSE MUSCULOSKELETAL PAIN , 2003, International journal of clinical practice.

[202]  P. Rose,et al.  Prevalence of aortic root dilation in the Ehlers-Danlos syndrome , 2002, Genetics in Medicine.

[203]  Kurt P. Spindler,et al.  The Effect of the Menstrual Cycle on Anterior Cruciate Ligament Injuries in Women as Determined by Hormone Levels , 2002, The American journal of sports medicine.

[204]  E. Rubin,et al.  Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition , 2002, Nature Genetics.

[205]  J. Schalkwijk,et al.  A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. , 2001, The New England journal of medicine.

[206]  P. Toti,et al.  Absence of the inferior labial and lingual frenula in Ehlers-Danlos syndrome , 2001, The Lancet.

[207]  P. Tsipouras,et al.  Orthopaedic Manifestations of Ehlers-Danlos Syndrome , 2000, Clinical orthopaedics and related research.

[208]  L. Walker,et al.  Mutational analysis of the lysyl hydroxylase 1 gene (PLOD) in six unrelated patients with Ehlers‐Danlos syndrome type VI: Prenatal exclusion of this disorder in one family , 2000 .

[209]  J. Schaffer,et al.  Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos syndrome. , 2000, American journal of obstetrics and gynecology.

[210]  L. Lagae,et al.  Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. , 2000, American journal of human genetics.

[211]  J. D. Allen,et al.  Deletion of cysteine 369 in lysyl hydroxylase 1 eliminates enzyme activity and causes Ehlers-Danlos syndrome type VI. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[212]  D. Jacome Headache in Ehlers—Danlos Syndrome , 1999, Cephalalgia : an international journal of headache.

[213]  Kazuro Furukawa,et al.  Molecular Basis for the Progeroid Variant of Ehlers-Danlos Syndrome , 1999, The Journal of Biological Chemistry.

[214]  H. Calkins,et al.  Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. , 1999, The Journal of pediatrics.

[215]  W. Reardon,et al.  Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. , 1999, American journal of human genetics.

[216]  E. McFarland,et al.  Joint surgery in Ehlers-Danlos patients: results of a survey. , 1999, American journal of orthopedics.

[217]  D. Grange,et al.  A patient with Ehlers-Danlos syndrome type VI is homozygous for a premature termination codon in exon 14 of the lysyl hydroxylase 1 gene. , 1999, Molecular genetics and metabolism.

[218]  R. Grahame Joint hypermobility and genetic collagen disorders: are they related? , 1999, Archives of disease in childhood.

[219]  T. Spector,et al.  Assessment of bone in ehlers danlos syndrome (EDS) by ultrasound and densitometry , 1998, Osteoporosis International.

[220]  A. El-Garf,et al.  Hypermobility among Egyptian children: prevalence and features. , 1998, The Journal of rheumatology.

[221]  P. Beighton,et al.  Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). , 1998, American journal of medical genetics.

[222]  S. Kügler,et al.  Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a novel point mutation (W612C) , 1998, Archives of Dermatological Research.

[223]  S. Krane,et al.  Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. , 1997, American journal of medical genetics.

[224]  J. Bristow,et al.  Tenascin–X deficiency is associated with Ehlers–Danlos syndrome , 1997, Nature Genetics.

[225]  P. Tsipouras,et al.  Chronic pain is a manifestation of the Ehlers-Danlos syndrome. , 1997, Journal of pain and symptom management.

[226]  P. Dongen,et al.  Hypermobility in two Dutch school populations. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[227]  J. Chambers,et al.  Extra-articular features of benign joint hypermobility syndrome. , 1996, British journal of rheumatology.

[228]  K. Janaki,et al.  Joint hypermobility in south Indian children. , 1996, Indian pediatrics.

[229]  C. Lethias,et al.  Flexilin: a new extracellular matrix glycoprotein localized on collagen fibrils. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[230]  B. Kousseff,et al.  Peripheral neuropathy in Ehlers-Danlos syndrome. , 1995, Pediatric neurology.

[231]  R. Baxendale,et al.  The effect of the hypermobility syndrome on knee joint proprioception. , 1995, British journal of rheumatology.

[232]  P. Narcisi,et al.  A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen. , 1994, Human molecular genetics.

[233]  W. Ferrell,et al.  Impaired proprioceptive acuity at the proximal interphalangeal joint in patients with the hypermobility syndrome. , 1994, British journal of rheumatology.

[234]  I. Hausser,et al.  Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I–IV as a means of diagnostics and classification , 1994, Human Genetics.

[235]  S. Pinnell,et al.  A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. , 1994, Journal of Clinical Investigation.

[236]  G. S. Mudholkar,et al.  Hypermobility: prevalence and features in a Swedish population. , 1993, British journal of rheumatology.

[237]  J. Vallejo,et al.  Anxiety disorders in the joint hypermobility syndrome , 1993, Psychiatry Research.

[238]  L. Ala‐Kokko,et al.  A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers–Danlos syndrome type VI , 1992, Nature Genetics.

[239]  B. Blumberg,et al.  Characterization of a COL1A1 splicing defect in a case of Ehlers-Danlos syndrome type VII: further evidence of molecular homogeneity. , 1991, American journal of human genetics.

[240]  A. Nicholls,et al.  Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen α2(I) chain , 1991, Human Genetics.

[241]  R. Weksberg,et al.  A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype. , 1991, American journal of human genetics.

[242]  L. Arendt-Nielsen,et al.  Insufficient effect of local analgesics in Ehlers Danlos type III patients (connective tissue disorder) , 1990, Acta anaesthesiologica Scandinavica.

[243]  E. Quentin,et al.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[244]  A. Leung,et al.  Oral manifestations of Ehlers-Danlos syndrome. , 1989, Journal of the American Dental Association.

[245]  S. Kurata,et al.  Existence of malfunctioning proα2(I) collagen genes in a patient with a proα2(I)‐chain‐defective variant of Ehlers‐Danlos syndrome , 1988 .

[246]  D. Sillence,et al.  International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. , 1988, American journal of medical genetics.

[247]  M. el Mauhoub,et al.  Ehlers Danlos syndrome--masquerading as primary muscle disease. , 1988, Postgraduate medical journal.

[248]  E. Quentin,et al.  Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid. , 1987, American journal of human genetics.

[249]  W. Cole,et al.  Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. , 1986, The Journal of biological chemistry.

[250]  E. Giannini,et al.  Hypermobility of the joints in juvenile episodic arthritis/arthralgia. , 1985, The Journal of pediatrics.

[251]  A. Child,et al.  Mitral valve prolapse, aortic compliance, and skin collagen in joint hypermobility syndrome. , 1985, British heart journal.

[252]  J. Aldridge,et al.  A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain. , 1985, The Journal of biological chemistry.

[253]  A. Weiland,et al.  Painful subluxation of the carpometacarpal joint of the thumb in Ehlers-Danlos syndrome. , 1985, The Journal of hand surgery.

[254]  P. Byers,et al.  Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders. , 1982, The Journal of investigative dermatology.

[255]  M. Spengos,et al.  Brachial neuropathy and Ehlers‐Danlos syndrome , 1981, Neurology.

[256]  L. Peltonen,et al.  Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII. , 1980, The Journal of biological chemistry.

[257]  C. Leier,et al.  The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. , 1980, Annals of internal medicine.

[258]  K. Kayed,et al.  Acute multiple brachial neuropathy and Ehlers‐Danlos syndrome , 1979, Neurology.

[259]  P. Beighton Articular manifestations of the Ehlers-Danlos Syndrome. , 1972, Seminars in arthritis and rheumatism.

[260]  P. Beighton,et al.  Surgical aspects of the Ehlers‐Danlos syndrome a survey of 100 cases , 1969, The British journal of surgery.

[261]  C. Tinelli,et al.  Absence of lingual frenulum in children with Ehlers-Danlos Syndrome: a retrospective study of forty cases and literature review of a twenty years long debate. , 2019, Minerva pediatrica.

[262]  M. Pasek,et al.  Prevalence of generalised joint hypermobility in school-aged children from east-central European region. , 2016, Folia morphologica.

[263]  C. Hawk,et al.  Clinical Practice Guideline: Chiropractic Care for Low Back Pain. , 2016, Journal of manipulative and physiological therapeutics.

[264]  G. Pailhez,et al.  Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. , 2015, General hospital psychiatry.

[265]  C. Giunta,et al.  Kyphoscoliotic type of Ehlers-Danlos Syndrome (EDS VIA) in six Egyptian patients presenting with a homogeneous clinical phenotype , 2014, European Journal of Pediatrics.

[266]  T. Smith,et al.  The relationship between benign joint hypermobility syndrome and psychological distress: a systematic review and meta-analysis. , 2014, Rheumatology.

[267]  C. Bönnemann,et al.  Molecules in Focus: Collagen XII: Protecting bone and muscle integrity by organizing collagen fibrils , 2014 .

[268]  L. Mainardi,et al.  Postural analysis in time and frequency domains in patients with Ehlers-Danlos syndrome. , 2011, Research in developmental disabilities.

[269]  L. Afrin,et al.  Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. , 2011, Journal of hematology & oncology.

[270]  N. Morling,et al.  Brittle cornea syndrome associated with a missense mutation in the zinc-finger 469 gene. , 2010, Investigative ophthalmology & visual science.

[271]  G. Piérard,et al.  Collagen Fibril Arabesques in Connective Tissue Disorders , 2006, American journal of clinical dermatology.

[272]  P. D. De Coster,et al.  Generalized joint hypermobility and temporomandibular disorders: inherited connective tissue disease as a model with maximum expression. , 2005, Journal of orofacial pain.

[273]  A. Paepe,et al.  Human Fibroblasts with Mutations in COL 5 A 1 and COL 3 A 1 Genes Do Not Organize Collagens and Fibronectin in the Extracellular , 2004 .

[274]  S. Wallis,et al.  Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype. , 2001, Journal of medical genetics.

[275]  L. Assael,et al.  Orthodontic and temporomandibular joint considerations in treatment of patients with Ehlers-Danlos syndrome. , 1997, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[276]  A. Silman,et al.  High prevalence of joint laxity in West Africans. , 1994, British journal of rheumatology.

[277]  P. Helliwell Impaired proprioceptive acuity at the proximal interphalangeal joint in patients with the hypermobility syndrome. , 1994, British journal of rheumatology.